Organisers are calling for entrants for this year's Vet Charity Challenge, an outdoor sporting fundraiser which also serves as a team building event for practices.
Competitors take part in walking, running, cycling and kayaking challenges, along with some orienteering and mental and physical tasks, in teams of four.
The event will take place on Saturday 28th September at Pershore College, Worcestershire.
Organisers say the Vet Charity Challenge has been designed for every level of fitness and success on the day depends very much on how well each team member works together, rather than physical fitness.
Jason Rogers, one of the VCC organisers said: "Teams are registering every day and we are delighted with the response. But there are a few team spaces left, so I urge practices to register a team of four online now at: www.vetcharitychallenge.co.uk."
The Vet Charity Challenge 2012 raised a total of £21,000, which was shared between three animal charities. The event in 2013 will raise funds for Hearing Dogs for the Deaf, SPANA and Animals Asia.
Sue, who is President of the European Society of Dermatology and an RCVS Specialist, says in a video interview that antimicrobial resistance (AMR) is making otitis externa cases difficult to resolve and that vets can help overcome the problem by rethinking their first line prescription choices.
In the video, created in conjunction with Elanco Animal Health (maker of Osurnia), Sue said: "It’s a sad thing to say but if everybody did manage cases of otitis externa appropriately first time, I probably wouldn’t have a job at all."
"Many of the cases I see as a referral clinician are longstanding cases with very severe, multiply-resistant infections. If we get these cases right on the first occasion with appropriate prescription of drugs, and we don’t hurt dogs so we can give ongoing treatment, then we’d never ever see pseudomonas infection again."
Sue believes part of the problem is that veterinary surgeons are incorrectly saving some of their best first-line treatments for difficult cases. This is perpetuating the antimicrobial resistance problem as cases are being inadvertently mismanaged.
She said: "Florfenicol, which is the active antibiotic in Osurnia, has excellent gram positive activity which makes it an ideal first line choice. However, there’s a misconception that florfenicol is a fluoroquinolone - which it isn’t - so vets are incorrectly ‘saving it’ rather than using it on the first occasion."
Sue also highlights that poor compliance, resulting from the patient’s behavioural problems associated with ear phobia, also has a long-term impact:
"We’ve seen many 'well behaved' dogs that have bitten their owners as a result of fear aggression; we’ve had dogs that have pinned their owners against the wall. I would argue very strongly that if you use long-acting products in dogs on the first occasion then you avoid creating that problem and these dogs don’t become difficult to medicate on a long-term basis."
Sue summarised two factors that vets need to consider when deciding on the appropriate treatment: the right active ingredients to target common first-line pathogens; and the method of application. She urged vets to consider using a long-acting product applied within the practice, removing the need for home treatment to reduce stress for both owner and the dog, improve long-term compliance and maximise clinical outcomes.
To hear Sue’s tips on how to treat cases of otitis, watch the video here – www.osurnia.co.uk
The courses, which are are aimed at practitioners dealing with species other than companion animals, include:
Emergency Care of Alpacas (13 July, Sheffield)This course covers the management of dystocia and other problems in the peri-parturient female and neonate, resuscitation, common congenital problems, the failure of passive immune transfer and septicaemia. First aid for orthopaedic emergencies and wound care is covered as is working up the colic patient and the neurological patient.
Diseases of Game Birds (20 June, Swindon; 5 September, Sheffield)Aimed at ensuring that the veterinarian is able to deal with the demands of gamekeepers and game rearers, this course offers an overview of the industry and legislation, together with biosecurity and its application to wild birds. It includes review of common disease processes and control of antibiotic usage with some applied alternatives to traditional methods.
First Aid for the Large Animal Vet (5 July, Swindon; 2 August, Sheffield)This course is aimed at assisting large animal vets who may find themselves required to offer first aid to a colleague who has sustained injuries during a farm visit. It provides advice on assessing emergency situations, recognising and treating fractures, carrying out artificial ventilations and chest compressions, controlling severe bleeding and dealing with burns and scalds.
The Approach to the Sick Hen (18 July, Swindon; 13 September, Sheffield)Avian anatomy and the husbandry of the backyard flock are covered in this course, together with worming and vaccination advice, the approach to the sick hen and appropriate medication options.
Veterinary Care of Sheep (11 July, Swindon; 6 July, Sheffield) Covering the basics of best practice and flock health planning, this course provides practical advice on maximising lamb numbers, sheep lameness, controlling internal and external parasites and flock vaccination programmes.
Veterinary Care of Goats (10 July, Swindon) This course covers the behavioural, nutritional and environmental needs of goats across all sectors, including pet, meat, pedigree and commercial dairy goats. It also covers infectious diseases affecting goats in the UK, including diagnosis, treatment and control, in addition to disbudding, foot care and common surgical procedures.
David Babington MRCVS, Managing Director of Improve, said: "We introduced a number of one-day short courses in niche or emerging areas of veterinary medicine last year and have built on the range for 2017 to cover new species including chickens and goats. Most of the courses are offered in venues in both the north and south of the UK. We look forward to welcoming vets to these new courses this year."
Further information is available at http://www.improveinternational.com/uk/#top
The annual minimum requirement for vets will be reduced from 35 to 26 hours of CPD, while that of veterinary nurses will be reduced from 15 to 11 hours. The reduction comes into force immediately.
A similar 25% reduction will also be introduced for veterinary surgeons holding Advanced Practitioner or RCVS Specialist status.
The decision to reduce the hours was made by the new RCVS Council COVID-19 Taskforce, chaired by RCVS President Dr Niall Connell, which was set up in order to make temporary policy decisions related to the pandemic in a quicker and more agile way. The proposal had previously been considered and supported by the RCVS Education Committee, VN Council and CPD Policy Working Group.
Niall said: “A number of veterinary surgeons and veterinary nurses expressed concern that it may be difficult to undertake CPD at present and so, in order to give the professions some breathing space, we decided we would reduce the minimum hours required for 2020. We also recognise that some practices are having to make the difficult decision to reduce their CPD budgets this year in response to falling footfall.
"However, it is worth reiterating that CPD need not be expensive or require physical attendance at lectures, congresses or other events. There are many online providers of CPD and other resources such as articles and webinars, some of which may be free. The key is that the CPD is relevant to you and enhances your professional practice and so we would still encourage all our members to undertake CPD as and when they can."
The policy will be under regular review and may be extended further if the circumstances demand. Those with any questions on the policy change should contact the RCVS Education Department on cpd@rcvs.org.uk
A full range of FAQs on the COVID-19 pandemic and the impact on the veterinary profession are available to view at www.rcvs.org.uk/coronavirus
The company initiated the recall after identifying a potential for the sterility/stability of the product to be compromised due to a crimping problem of the aluminium cap.
The recall is for the 100 ml bottles of the following batch only:
Batch No.0C3829 Expiry Date 03/12/2022
Vetoquinol UK Ltd is contacting veterinary surgeons and veterinary wholesalers to examine inventory immediately and quarantine products subject to this recall.
For further information, contact the Customer Services Department on +44 1280 814500 Option 1 or email: UK_office@vetoquinol.com.
CEVA Animal Health has announced that its live enzootic abortion vaccine, CEVAC® Chlamydophila, now has an added benefit. It can be used simultaneously with the only available toxoplasmosis vaccine. According to CEVA, infectious abortion, particularly enzootic abortion (Chlamydiosis), has been known to wipe out up to 50% of lambs. Strategic use of CEVAC® Chlamydophila, a live enzootic abortion vaccine, can not only prevent abortion but can also control excretion and the threat of infection.
The company says: "CEVAC® Chlamydophila makes practical and economic sense. A vaccination every four years will help your clients’ flocks remain chlamydiosis-free and the cost of treatment should work out at well under 75p per sheep per year. This is a tiny investment for your clients, to prevent the financial loss of an abortion. The fact that the product can now be used on the same day as the toxoplasmosis vaccine means that is now one of the most convenient and affordable methods currently available."
Ideally routine preventative measures should be taken prior to mating and when new sheep are introduced to the flock, to ensure abortion and infection rates always remain as low as possible.
All animals should be vaccinated in the first year, with replacements being vaccinated from six months of age, at least four weeks prior to tupping.
CEVAC® Chlamydophila is quick and easy to administer, using the special, multi-dose injector gun. One bottle of vaccine contains enough for 20 doses.
For further product information contact your local CEVA representative or CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG or visit the website at http://www.ceva.uk.com/
Pfizer Animal Health has confirmed that the agreement to acquire multiple product franchises from the Schering-Plough Corporation has been completed - and approved by the European Commission. Pfizer has acquired these assets for approximately euro 116 million in cash.
The agreement covers all European Union countries and the franchises include all major animal health species including cattle, swine, equine and companion animal. Pfizer executives say the agreement leaves them with the most in-depth coverage of therapeutic areas, and the most highly recognised brands, in the industry. Precise details of the agreement are not being released although additional information on the products concerned will be the subject of further announcements in due course.
Pfizer has acquired certain rights to the following products in the European Economic Area:
Albert Bourla, President of Pfizer Animal Health in Europe, said: "This represents a significant expansion of our product portfolio and strengthens our long term commitment not just to veterinary surgeons, but also to farmers and pet owners. Pfizer spends hundreds of millions of dollars on research and development every year, and brings more new products to market than any other company, but when the opportunity arose to add well known, well respected brands to a portfolio that is already extremely strong, we had little hesitation in taking it."
CEVA Animal Health has extended its behavioural range of products with the launch of Senilife®, a nutritional supplement which is specifically formulated to help manage signs of brain ageing in dogs and cats.
Senilife® contains a combination of three essential brain nutrients - phosphatidylserine, vitamin B6 and vitamin E - which the company says help maintain membrane fluidity and normalise neurotransmission. In addition, two natural but potent anti-oxidants - gingko biloba and resveratrol - support brain metabolism and help to neutralise free radicals and reduce amyloid deposits.
According to CEVA, common signs of brain ageing in dogs and cats include playing or interacting less, barking or howling at night, loss of house-training/litter box training, apathy or increased tiredness and disorientation. A study has shown that up to 75% of dogs over seven years of age and 35% of cats 11 years and over suffer from at least one geriatric behavioural problem1.
In a recent clinical study, 86% of owners were satisfied with the results achieved after one month of using Senilife®, with 73% of dog owners and 67% of cat owners noticing fewer signs of brain ageing within the first seven days2.
Juliet Penaliggon, small animal marketing manager at CEVA Animal Health, says: "Many typical signs of brain ageing in dogs can be controlled by nutritional management. Senilife® is a fast-acting, nutritional supplement that contains proven nutrients and neuroprotectives to help manage these signs."Senilife® capsules are easy to administer either directly into the mouth of the pet or emptied onto the pet's food."
For further information, please contact your CEVA Animal Health representative or call 01494 781510.
References1 Behaviour problems in geriatric pets. Lansberg G and Araujo J. Vet Clin North Am Small Anim Pract. 35 (2005) 675-698.2 Isaka N, Baysse B, Lopez A, Ovaert P and Penaliggon J. CABSTG Spring Meeting April (2009).
Congratulations to VetSurgeon members Mike Martin, Malcolm Ness and Mark Patteson, who were amongst the winners of the 2010 BSAVA Annual Awards.
Mike Martin actually collected two awards this year: The Dunkin Award for the author of the most valuable article published in the Journal of Small Animal Practice (Canine dilated cardiomyopathy: a retrospective study of signalment, presentation and clinical findings in 369 cases), and the Blaine Award presented by Royal Canin for outstanding contributions to the advancement of small animal medicine or surgery.
Malcolm Ness won the Simon Award for outstanding contributions in the field of veterinary surgery.
Mark Patteson picked up the Melton Award, presented annually by Royal Canin for meritorious contributions by veterinary surgeons to small animal veterinary practice.
Other winners included Iona Mathieson (Frank Beattie Travel Scholarship), Anne Vaughan-Thomas (deceased) (Amoroso Award), David Church (Woodrow Award), Luke Gamble (J.A. Wright Memorial Award), Olaf Reinhard Schaaf (Petsavers Award) and Steve Withrow (Bourgelat Award).
Intervet/Schering-Plough Animal Health has produced a new medicine record book to help producers effectively document animal health product usage, to coincide with the cattle pneumonia season.
The Resflor-sponsored booklet incorporates space to record all the necessary information to comply with legislative requirements.
Intervet/Schering-Plough livestock veterinary adviser Paul Williams MRCVS said: "If you are in the business of rearing, producing or treating farm animals that will end up as food for human consumption, you must keep a record of any veterinary medicinal product you give or treat them with.
"You must also keep proof of purchase of all veterinary medicinal products and keep all your records for a period of five years. A format for keeping all these records is set out in this book."
To order Resflor medicine record books to give your clients, ring: 01694 731777
Petplan has revealed the top 10 most claimed for health conditions in cats and dogs for 2011.
They were:
The peer-reviewed manual, available for download from the VMG website, has been designed to be relevant for any veterinary business and has been developed following a review of the contemporary academic and business literature, with input from the VMG Board of Directors.
The Business Re-emergence Manual guides readers through three main areas that need to be considered as they emerge from lockdown:
VMG President Richard (Rich) Casey said: “Depending on the circumstances in which businesses entered the pandemic, it’s likely that they will be affected by a range of people, planet and profit-related issues as lockdown restrictions start to ease.
"Our Business Re-emergence Manual encourages veterinary leaders to take a step back and reflect on how their business was performing before the pandemic as a first step before starting to make plans for their future operations. Investing in this ‘thinking time’ now will enable them to ramp up more quickly and more effectively when the time is right. It is an evidence-based and highly practical tool which all veterinary businesses can work through and we hope they will find it useful as they start to plan for a successful future.”
To support veterinary practices and staff affected by the COVID-19 emergency, the Veterinary Management Group (VMG) is pausing subscription renewals for all of its existing members for three months, in effect, giving them three months’ free membership, including access to resources such as the Business Re-emergence Manual. It is also offering everyone in the sector the opportunity to join the association for three months, also free of charge.
The Royal College of Veterinary Surgeons is stressing the need for employers to check the registration status of the veterinary surgeons and veterinary nurses they recruit.
This comes following several incidences where veterinary surgeons have been found to be either not registered or registered in the wrong category. For example, foreign nationals wishing to work in the UK must be registered as home-practising members, not overseas-practising members. The latter category is for those practising overseas who wish to retain their MRCVS status.
Furthermore, there have been some cases of veterinary surgeons registering as ‘non-practising' and going on to carry out veterinary nursing roles, in the absence of relevant qualifications or being listed/registered as a veterinary nurse. This may be happening in cases where overseas veterinary surgeons are struggling to find work in the UK, possibly due to language difficulties.
RCVS President Jill Nute said: "Vets and veterinary nurses have complementary roles within the practice team. If someone wishes to undertake a veterinary nursing role, they should be qualified and registered as such. Many skills are taught in the veterinary nursing training that are not included in the veterinary degree. Although some veterinary nursing tasks can be carried out by veterinary surgeons, they certainly must not be undertaken by those who are not on the RCVS Register of Veterinary Surgeons".
She added: "Ours is a self-regulated profession and it is important that employers play their part by ensuring that practice employees are appropriately qualified and registered".
The registration status of vets and veterinary nurses can be checked on RCVSonline at: www.rcvs.org.uk/checkregister or www.rcvs.org.uk/vnlist respectively.
The National Office of Animal Health (NOAH) has launched a new 'Use Medicines Responsibly' campaign.
The main thrust of the campaign is an initiative by NOAH to encourage pharmaceutical companies to add: 'Use Medicines Responsibly' as a strapline to their own advertising campaigns, with a link to the NOAH information resource for prescribers and users of animal medicines: www.noah.co.uk/responsible.
Speaking at the NOAH annual members' conference in Northampton, NOAH chief executive Phil Sketchley said: "NOAH believes responsible promotion of animal medicines to be an important link in the chain towards responsible use. Companies' promotional material can educate prescribers and users of animal medicines to the benefit of their animals' health and welfare.
"We believe this new advice resource, with the reminder on advertisements, will help."
Petplan, the pet insurance provider has been selected as a Which? Best Buy. The independent consumer guide selected Petplan's 'Covered For Life' policy that covers animals for accidents and illnesses, including reoccurring conditions, such as diabetes and glaucoma, year after year, as long as the policy is renewed annually.
Alison Andrew, Petplan's Marketing Manager said: "The Which? report is crucial to being acknowledged as a worthy pet insurance provider. We feel being selected as a Which? Best Buy reflects how we treat our customers by offering excellent customer service, paying claims quickly, discounts on pet products and regular information about pet care through our magazine PetPeople."
Petplan provides insurance cover for dogs, cats, rabbits and horses and is the largest provider of animal health insurance in the world.
National charity Canine Partners, which provide specially trained assistance dogs to people with disabilities, will benefit from an Eastbourne vet's efforts to run the Brighton Marathon on Sunday 10th April in less than 3.5 hours.
Simon DeVile is undertaking a gruelling training scheme, covering up to 50 miles a week, to ensure peak performance when he takes to the streets to raise money for Canine Partners - a charity close to his heart.Simon, 44, is one of the partners at St. Anne's Veterinary Group in Eastbourne. He started running to keep fit in 2006 and has since run the London Marathon twice and the Beachy Head Marathon three times. Simon regularly comes into contact with canine partner puppies because a local fundraiser and puppy parent is one of his clients. His own dog is also part of a locally bred litter, five of which went on to train as canine partners.Simon said: "I wanted to enjoy a new marathon experience this Spring and Brighton proved very popular last year. My aim is to enjoy the race but hopefully get below 3hrs 30 mins and raise money for Canine Partners. I am very aware what an important role these dogs play in the lives of a person with disabilities. I am also continually impressed with the way Canine Partners look after the dogs in their care so well."
If you would like to support Simon's efforts, visit: http://www.justgiving.com/Simon-DeVileCanine Partners still has charity places available for The Brighton Marathon. If you would like to take up the challenge, please contact Jill Green on 01730 716014.
The British Equine Veterinary Association (BEVA) has launched two guides to help veterinary professionals and their clients negotiate the complexities of equine insurance.
BEVA highlights that with up to 40% of horses becoming ill or injured in any one year and 25% of insured horses having a claim in any one year, vet fees insurance is a sensible way for horse owners to budget for unexpected healthcare costs.
The Veterinary Surgeon's guide to riding and sport horse insurance provides general guidelines to help vets understand the requirements and issues relating to equine insurance. It explains the three main types of insurance cover available: veterinary fees, death and permanent loss of use, as well as insurance recommendations for pre-purchase and pre-insurance vetting. The final section contains a jargon-busting guide to commonly used insurance terminology.
Complementing the vet guide is The BEVA leisure and sports horse Insurance Guide for horse owners, a handout for clients about to embark on taking out insurance. It covers the frequently asked questions relating to vets fees and death, including when and how to insure, the importance of pre-purchase vetting, exclusions and permanent loss of use.
Andrew Harrison, Junior Vice President of BEVA, said: "Whether a vet or a horse owner, understanding equine insurance can be intimidating for the best of us. The new guides should make it easier for you and your clients to understand the finer points of policies, premiums and claim protocols."
The guides can be downloaded from the BEVA website via the following links:
For additional information visit www.beva.org.uk
The British Equine Veterinary Association (BEVA) is urging veterinary surgeons to be on the lookout for outbreaks of Atypical Myopathy (AM) this spring.
Atypical Myopathy is a serious muscle disease found in the UK and Northern Europe. It is linked to horses eating the seeds from trees in the Acer family, including sycamore and box elder. There were more than five times as many cases of AM last autumn than in the previous year and experts have warned that the disease tends to occur more frequently in the spring following an autumn surge, possibly because of the growth of seedlings. The prognosis is poor, with survival rates of less than 25%. Early diagnosis is essential to give the best chance of survival.
Horses that develop AM are usually kept on sparse pastures, near trees from Acer pleudoplatanus (sycamore) or Acer negundo (box elder, pictured right) that shed seeds containing the toxin hypoglycin A. They are often not fed any supplementary hay or feed and may be driven to browse on an accumulation of dead leaves, dead wood and trees in or around the pasture but sometimes well-fed animals are affected. While the tree seeds may not be directly palatable, horses on poor quality grazing may ingest considerable numbers of them.
The clinical signs of AM may include muscle weakness or stiffness, colic-like symptoms, laboured breathing, dark red-brown urine, recumbency or even sudden death. Often the disease will present as an outbreak. Confirmation of diagnosis is by a blood or urine test. The toxin directly targets aerobic energy metabolism so therapy should be targeted at promoting glucose metabolism and provided fluid dieresis.
Preventative advice for horse owners includes:
Professor Celia Marr, Partner at Rossdales, Newmarket, European Specialist in Equine Internal Medicine and Editor of Equine Veterinary Journal said: "New, collaborative research, instigated last year between the University of Liege, the Irish Equine Centre and the Animal Health Trust should shed more light on the characteristics of the disease in this country. Once we know more about the specific causes we should be able to make more positive progress with prevention strategies."
BEVA has provided free online access to two articles from the journal of Equine Veterinary Education on the disease for all vets to help them address the threat.
Volume 25, Issue 5, pages 264-270, May 2013
Management of cases suffering from atypical myopathy: Interpretations of descriptive, epidemiological and pathophysiological findings. Part 1: First aid, cardiovascular, nutritional and digestive care (pages 264-270) G. van Galen and D -M Votion.
Volume 25, Issue 6, pages 308-314, June 2013
Management of cases suffering from atypical myopathy: Interpretations of descriptive, epidemiological and pathophysiological findings. Part 2: Muscular, urinary, respiratory and hepatic care, and inflammatory/infectious status (pages 308-314) G van Galen and D - M Votion.
The aim of the study was to assess the adverse effect profile of each individual AED by analysing all available data that has been published for each specific AED and then evaluating how reliable the data was. The study was published in BMC Veterinary Research (DOI: 10.1186/s12917-016-0703-y).
To do this the researchers gathered, screened and assessed all the information published in peer-reviewed journals and publications. The individual studies were then evaluated based on the quality of evidence, study design, study group sizes, subject enrolment quality and overall risk of bias. The results, say researchers, now provide a new and more objective insight into the tolerability and safety of the AEDs.
Co-author of the study, Marios Charalambous, said: "We recruited systematic and statistical methods to combine, compare and summarize the results of independent studies and, therefore, create more objective and reliable conclusions based on the current evidence. It was a time-consuming, demanding and challenging process, but we are sure that we provide the clinicians now with essential information which they can use for daily practice."
By reviewing, assessing and untangling the vast amounts of data, the researchers found that much of the evidence for the medical treatment of canine epilepsy was based on subpar reporting of adverse effect and in studies that were below the expected standard. They say that only in recent years can the quality of studies carried out be considered adequate.
Professor Holger Volk, Clinical Director of the RVC Small Animal Referral Hospital and Professor of Veterinary Neurology and Neurosurgery (pictured right), said: "Not only does this study offer a new perspective on the management of canine epilepsy, but also highlights the importance of the need for trials which provide high quality evidence in order to have more reliable and objective results about the safety and tolerability of the AEDs in veterinary medicine."
Dr. Dave Brodbelt, Senior Lecturer in Companion Animal Epidemiology, added: “This is a valuable addition to the body of literature on canine epilepsy, highlighting safety issues and adverse events related to its management and adding further depth to the evidence base relevant to practicing vets."
The four-day course, which is organised by Embryonics, will take place in Cheshire and runs from Monday 24 February to Thursday 27 February.
The course will cover the five-step Dutch method of foot trimming, which Ceva says is the most successful tried and tested method of trimming for reducing the incidence of lameness in the herd.
Course tutors include John Dawson MRCVS BVMS CertCHP Dip Cattle footcare and a Ceva representative will also present information on how the management of pain and inflammation fits into a comprehensive lameness treatment programme. The practical course is a recognised route to becoming a NACFT (National Association of Cattle Foot Trimmers) licensed foot trimmer.
Peter Keyte, ruminant business unit manager at Ceva, comments: "We would like to encourage livestock vets, farmers and professional foot trimmers to work more closely together, as a team, to help prevent lameness in cattle. We are therefore delighted to be supporting the industry by sponsoring this course, which will help raise welfare standards across the industry."
For further information on the Professional Foot Trimming course, please visit www.embryonicsltd.co.uk.
The route covers a distance of approximately 400 miles.
Oscar said: “My goals for the event are to raise awareness about mental health within the veterinary profession and demonstrate how being in the countryside can boost wellbeing. Along the way, I’m keen to fundraise as much as possible for Vetlife.
“Vetlife has done so much for the veterinary profession with regards to making mental health support more accessible.
"Having that knowledge that they are there personally provides a lot of comfort in what can sometimes be quite a lonely and isolating profession.”
Fellow cyclist and Vetlife trustee Danny Chambers said: “I know how painful it is to cycle up Cheddar Gorge in North Somerset, so I am in awe that Oscar is cycling a 400-mile route around that terrain to visit every vet practice in Somerset in 2 days.
"I’m sure in his brief visits to each practice he’ll get a warm welcome and some sustenance to help him along to his next pit stop!
"Thank you to Oscar for his enthusiasm and support.”
Oscar is inviting others in the veterinary community to join sections of the journey along the way.
For more information on how to get involved with the cycle, visit the Somervet Facebook group: https://www.facebook.com/groups/1930480070643515.
Donate to the fundraiser via the Somervet JustGiving page: https://www.justgiving.com/page/ride-somervet
CVS says the use of ear cytology in OE is beneficial, both as a diagnostic and to evaluate the response to therapy.
However, in 2019 the company looked at 26,269 of its patients and found that ear cytology was only being used in 19.2% of cases, in line with the rest of the profession.
Only 11% of cases were being provided with in-house point-of-care cytology, whilst 8.2% had it performed externally.
80.8% of patients with OE were being prescribed antibiotics without cytological support, with 5% of these the highest priority critically important antibiotics (HPCIAs).
This low level of cytology use in primary care was suspected to be a major contributory factor to the significant use of unnecessary antibiotics.
To support its practices, CVS first looked at the barriers to performing ear cytology interventions, which were identified as a lack of confidence in using the microscope (particularly focusing on x100 and identification of pathological events), a perceived lack of time, insufficient or poorly working equipment, a lack of access to equipment, and the perception that cytology does not change the treatment choice or outcome.
As a second step, a minimal list of cytology equipment was developed to ensure that all sites had the right kit.
New equipment was then supplied to a practice if it did not meet minimum standards.
The company then produced education and resource materials, including new guidelines, imagery and video guides, to upskill both its vets and nurses.
The training focused on: equipment maintenance, cleaning and troubleshooting, how to use the microscope – including x100 magnification and the slide oil immersion technique, how to identify pathological changes, and time management to get a consultation done – including swabbing, microscope analysis, diagnosis and client consultation.
Each site was then provided with its own data, so that it could monitor progress.
Elizabeth McLennan Green, CVS Clinical Director for the North, said: “One of our goals with this project was to minimise the number of antibiotics prescribed without associated diagnostics, and to use ear cytology to guide therapy and response to treatment for the benefit of our patients and clients.”
“We know that low ear cytology interventions are an issue across the profession. We wanted to do better. So ear cytology has been our first and longest running clinical improvement project.
"We’re thrilled with the brilliant results our colleagues are now achieving.”
There's a video presentation about the project here: https://vimeo.com/875515008/bdc3ee5920
Photo: Emily Spencer, Head Vet at Castle Vets
Mars says that during a typical anaesthetic procedure, less than five percent of the volatile anaesthetic agent delivered to a patient is absorbed and metabolised and about 95% is exhaled.
SageTech’s gas-capture technology – which is currently used in human healthcare – works by capturing the waste anaesthetic agent exhaled during an operation by adsorbing it into a reusable capture canister.
These waste anaesthetic agents can then be extracted from the filter, without incinerating or release them into the atmosphere.
Ellie West, RCVS and EBVS® European Specialist in Veterinary Anaesthesia and Analgesia, and Linnaeus Environmental Sustainability Lead, said: “As a leading provider of veterinary care, we have a responsibility to take climate action at scale and lead the way toward more sustainable practices.
“Our innovative collaboration should help us take a significant step forward in our sustainability journey, aimed at contributing to a better future for the planet – and the people and pets who depend on it.”
The one-year pilot will start with 10 Linnaeus primary care and referral veterinary practices in the UK, after which Mars says it plans to explore the potential application of this technology across other parts of its business.
https://www.sagetechveterinary.com
Virbac has launched Nutribound, a complementary feed to help stimulate eating and drinking in inappetent cats and dogs.
The company says the product has been designed to help animals recovering from surgery or illness and those that are just experiencing a general lack of interest in food or water.
Nutribound is given alongside the pet’s diet but can also be given by tube or syringe if needed.
Claire Lewis, Product Manager, said: "Pets that lose interest in their food can be challenging for owners to deal with - and a pet that is struggling to eat or drink what it needs, especially after illness or surgery is more likely to have a prolonged recovery.
"Nutribound's palatable formulation aims to 'jump-start' normal eating behaviour by stimulating the animal's appetite and increasing its interest in eating and drinking again.
"Nutribound is presented in a handy-sized, take-home bottle and is easy for pet owners to administer. It can be given for up to 14 days or until a return to normal eating and drinking behaviour is observed. We are delighted to add it to our nutritional support range, alongside Nutri-Plus gel, our high energy, nutritional supplement for cats and dogs."
The company says it believes it is the first major veterinary business in the UK to make this promise.
As a result of the pledge, salaries for about a third of the pet emergency firm's 1280 employees, including receptionists and animal care assistants, are set to increase to at least £9.50 an hour from April.
Vets Now says it has made the pledge on the recommendation of the Living Wage Foundation, which offers independent advice to employers and says £9.30 is now the real cost of living, not the Government-set national living wage of £8.72 for people aged 25 and over.
Vets Now’s chief executive Mark Ross said: "Our people are our biggest asset and at the heart of everything we do. We want to properly recognise the vital role each and every one of them plays in the business.
"This move demonstrates our commitment to that. We are confident that by paying all of our staff a competitive hourly rate of at least 20p more than the real living wage we will achieve higher morale and lower turnover."
Animal care assistant, Jody Reynolds, who works in Vets Now out-of-hours clinic in Kirkcaldy, said: “It’s amazing that Vets Now has been able to increase salaries to not only meet but exceed the real living wage. The extra will really help towards the cost of everyday living and even allow a few luxuries."